Who owns Inhibikase Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of IKT from SEC Form 13F filings across 76 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 76 institutions disclosed 46.6M shares of Inhibikase Therapeutics, Inc. worth $94.4M — about 26.7% of shares outstanding; the largest disclosed holder is Sands Capital Alternatives, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
76
13F holders
$94.4M
value, 2026 filers
26.7%
of shares outstanding (46.6M sh)
17
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of IKT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Sands Capital Alternatives, LLC | 13.0M | $26.4M | 4.3% | 7.5% | 0.0% |
| 2 | BlackRock, Inc. | 7.8M | $15.8M | 0.0% | 4.4% | +23.2% |
| 3 | Blackstone Inc. | 5.9M | $12.1M | 0.0% | 3.4% | 0.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.9M | $10.0M | 0.0% | 2.8% | -44.6% |
| 5 | MILLENNIUM MANAGEMENT LLC | 4.0M | $8.2M | 0.0% | 2.3% | +37.6% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.6M | $5.3M | 0.0% | 1.5% | +20.1% |
| 7 | NORTHERN TRUST CORP | 878,585 | $1.8M | 0.0% | 0.5% | +22.2% |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 809,490 | $1.6M | 0.0% | 0.5% | +31.0% |
| 9 | TWO SIGMA INVESTMENTS, LP | 806,264 | $1.6M | 0.0% | 0.5% | -4.9% |
| 10 | VANGUARD FIDUCIARY TRUST CO | 607,260 | $1.2M | 0.0% | 0.3% | +7.1% |
| 11 | Kennondale Capital Management LLCNEW | 565,983 | $1.1M | 0.8% | 0.3% | new |
| 12 | Pathstone Holdings, LLCNEW | 510,596 | $1.0M | 0.0% | 0.3% | new |
| 13 | Nuveen, LLC | 425,492 | $863,749 | 0.0% | 0.2% | -9.9% |
| 14 | JPMORGAN CHASE & CO | 316,574 | $610,988 | 0.0% | 0.2% | -3.6% |
| 15 | Bank of New York Mellon Corp | 303,126 | $615,346 | 0.0% | 0.2% | +42.2% |
| 16 | Sixth Street Partners Management Company, L.P.NEW | 275,041 | $558,333 | 0.1% | 0.2% | new |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 275,041 | $558,333 | 0.0% | 0.2% | +16.8% |
| 18 | UBS Group AG | 204,654 | $415,448 | 0.0% | 0.1% | -10.3% |
| 19 | BLAIR WILLIAM & CO/IL | 156,080 | $316,842 | 0.0% | 0.1% | -1.2% |
| 20 | ALPS ADVISORS INCNEW | 134,002 | $272,024 | 0.0% | 0.1% | new |
| 21 | JONES FINANCIAL COMPANIES LLLP | 128,491 | $245,418 | 0.0% | 0.1% | +299.0% |
| 22 | DEUTSCHE BANK AG\ | 126,677 | $257,154 | 0.0% | 0.1% | +3.5% |
| 23 | RHUMBLINE ADVISERS | 120,014 | $243,622 | 0.0% | 0.1% | +104.4% |
| 24 | MORGAN STANLEY | 114,006 | $231,432 | 0.0% | 0.1% | -30.6% |
| 25 | BANK OF AMERICA CORP /DE/ | 108,024 | $219,288 | 0.0% | 0.1% | -66.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.